用于医学目的的β-内酰胺类抗生素研究。十一。7-（D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）-α-（4-羟基苯基）乙酰胺基）-3-（（1-甲基-1H-四氮唑-5-基）硫甲基）-3-头孢烯-4-羧酸酯钠（T-1551）的代谢研究（作者译） - Suppr | 超能文献

[Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].

作者信息

Saikawa I, Nakashima Y, Sakai H, Momonoi K, Ikegami T, Minami H, Hayakawa H, Ochiai H, Todo Y

出版信息

Yakugaku Zasshi. 1980 Jun;100(6):625-40.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].用于医学目的的β-内酰胺类抗生素研究。十一。7-（D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）-α-（4-羟基苯基）乙酰胺基）-3-（（1-甲基-1H-四氮唑-5-基）硫甲基）-3-头孢烯-4-羧酸酯钠（T-1551）的代谢研究（作者译）

Yakugaku Zasshi. 1980 Jun;100(6):625-40.

2

[Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (T-1551) in aqueous solution (author's transl)].药用β-内酰胺类抗生素的研究。X. 7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯钠（T-1551）在水溶液中的稳定性及降解模式（作者译）

Yakugaku Zasshi. 1979 Dec;99(12):1207-18. doi: 10.1248/yakushi1947.99.12_1207.

3

[Studies on the absorption distribution and excretion of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-alpha-(4-hydroxyphenyl l) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].[14C标记的7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯（14C-头孢哌酮）在大鼠和小鼠体内的吸收、分布及排泄研究]

Jpn J Antibiot. 1980 Oct;33(10):1084-96.

4

[Pharmacological study of beta-lactam antibiotics (15). Metabolism of sodium 7 beta-[(2R,3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3- hydroxybutanamido]-7 alpha-methoxy-3- [1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (T-1982)].β-内酰胺类抗生素的药理学研究（15）。7β-[(2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-3-羟基丁酰胺基]-7α-甲氧基-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸钠（T-1982）的代谢

Yakugaku Zasshi. 1983 Apr;103(4):414-25.

5

[The autoradiographic studies on the distribution of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)-acetamido]-3-[(1-methyl -1 H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].[14C标记的7-[D(-)-α-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-α-(4-羟基苯基)乙酰胺基]-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯(14C-头孢哌酮)在大鼠和小鼠体内分布的放射自显影研究]

Jpn J Antibiot. 1980 Oct;33(10):1097-103.

6

[Studies on beta-lactam antibiotics for medicinal purposes. XXI. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (1)].用于医学目的的β-内酰胺抗生素研究。XXI. 对新戊酰氧基甲基(6R,7R)-7-[(Z)-2-(2-氨基噻唑-4-基)-2-甲氧基亚氨基乙酰胺基]-3-[(5-甲基-2H-四唑-2-基)甲基]-3-头孢烯-4-羧酸酯(T-2588)的代谢研究(1)

Yakugaku Zasshi. 1986 Jun;106(6):466-77.

7

[Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].[14C标记的7β-[(2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-3-羟基丁酰胺基]-7-甲氧基-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸酯（14C-T-1982）在小鼠和大鼠体内的吸收、分布及排泄研究]

Jpn J Antibiot. 1982 Sep;35(9):2163-73.

8

[Studies on beta-lactam antibiotics for medicinal purpose. XVII. Synthesis and structure-activity relationships of 7 beta-[D(-)-alpha-amino-alpha-(4-hydroxyphenyl)acetamido]-3-substituted methyl-3-cephem-4-carboxylic acids].

Yakugaku Zasshi. 1986 Feb;106(2):123-8.

9

[Studies on beta-lactam antibiotics for medicinal purpose. XIV. Stability and degradation pattern of sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4- carboxylate (T-1982) in aqueous solution].[药用β-内酰胺抗生素的研究。十四。7β-[(2R,3S)-2-(4-乙基-2,3-二氧代-1-哌嗪甲酰胺基)-3-羟基丁酰胺基]-7α-甲氧基-3-[(1-甲基-1H-四氮唑-5-基)硫甲基]-3-头孢烯-4-羧酸钠（T-1982）在水溶液中的稳定性及降解模式]

Yakugaku Zasshi. 1983 Jan;103(1):62-72. doi: 10.1248/yakushi1947.103.1_62.

10

[Studies on beta-lactam antibiotics for medicinal purpose. VI. Studies on the metabolism of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-phenylacetamido]penicillanic acid (T-1220) (author's transl)].药用β-内酰胺抗生素的研究。VI. 6-[D（-）-α-（4-乙基-2,3-二氧代-1-哌嗪甲酰胺基）苯乙酰氨基]青霉烷酸（T-1220）的代谢研究（作者译）

Yakugaku Zasshi. 1977 Oct;97(10):1071-81. doi: 10.1248/yakushi1947.97.10_1071.

引用本文的文献

1

Disposition of moxalactam and N-methyltetrazolethiol in rats and monkeys.莫西拉坦和N-甲基四氮唑硫醇在大鼠和猴子体内的处置情况。

Antimicrob Agents Chemother. 1987 Aug;31(8):1169-76. doi: 10.1128/AAC.31.8.1169.